Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors von Vikas, Praveen, Borcherding, Nicholas, Chennamadhavuni, Adithya, Garje, Rohan

Volltext

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma von Garje, Rohan, An, Josiah, Greco, Austin, Vaddepally, Raju Kumar, Zakharia, Yousef

Volltext

PARP Inhibitors in Prostate and Urothelial Cancers von Garje, Rohan, Vaddepally, Raju Kumar, Zakharia, Yousef

Volltext

Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria von Shrode, Rachel L., Knobbe, Jessica E., Cady, Nicole, Yadav, Meeta, Hoang, Jemmie, Cherwin, Catherine, Curry, Melissa, Garje, Rohan, Vikas, Praveen, Sugg, Sonia, Phadke, Sneha, Filardo, Edward, Mangalam, Ashutosh K.

Volltext

Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043 von Zakharia, Yousef, Singer, Eric A., Acharyya, Satwik, Garje, Rohan, Joshi, Monika, Peace, David, Baladandayuthapani, Veera, Majumdar, Annesha, Li, Xiong, Lalancette, Claudia, Kryczek, Ilona, Zou, Weiping, Alva, Ajjai

Volltext

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment von Garje, Rohan, An, Josiah J, Sanchez, Kevin, Greco, Austin, Stolwijk, Jeffrey, Devor, Eric, Rustum, Youcef, Zakharia, Yousef

Volltext

Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database st... von Avudaiappan, Arjun Pon, Prabhakar, Pushan, Sandman, Mayer Simcha, Rubens, Muni, Garje, Rohan, Eldefrawy, Ahmed, Manoharan, Murugesan

Volltext

Understanding the Redox Biology of Selenium in the Search of Targeted Cancer Therapies von Stolwijk, Jeffrey M., Garje, Rohan, Sieren, Jessica C., Buettner, Garry R., Zakharia, Yousef

Volltext

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma von An, Josiah, Packiam, Vignesh T, Chennamadhavuni, Adithya, Richards, Jordan, Jain, Jayanshu, Mott, Sarah L, Garje, Rohan

Volltext

Obesity diminishes response to PD-1-based immunotherapies in renal cancer von Boi, Shannon K, Orlandella, Rachael M, Gibson, Justin Tyler, Turbitt, William James, Wald, Gal, Thomas, Lewis, Buchta Rosean, Claire, Norris, Katlyn E, Bing, Megan, Bertrand, Laura, Gross, Brett P, Makkouk, Amani, Starenki, Dmytro, Farag, Kristine I, Sorge, Robert E, Brown, James A, Gordetsky, Jennifer, Yasin, Hesham, Garje, Rohan, Nandagopal, Lakshminarayanan, Weiner, George J, Lubaroff, David M, Arend, Rebecca C, Li, Peng, Zakharia, Yousef, Yang, Eddy, Salem, Aliasger K, Nepple, Kenneth, Marquez-Lago, Tatiana T, Norian, Lyse A

Volltext

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)-Their Incidence, Management, Multiorgan irAEs, and Rechallenge von Vaddepally, Raju, Doddamani, Rajiv, Sodavarapu, Soujanya, Madam, Narasa Raju, Katkar, Rujuta, Kutadi, Anupama P, Mathew, Nibu, Garje, Rohan, Chandra, Abhinav B

Volltext

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies von Swami, Umang, Chennamadhavuni, Adithya, Borcherding, Nicholas, Bossler, Aaron D., Mott, Sarah L., Garje, Rohan, Zakharia, Yousef, Milhem, Mohammed

Volltext

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence von Vaddepally, Raju K., Kharel, Prakash, Pandey, Ramesh, Garje, Rohan, Chandra, Abhinav B.

Volltext

427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma von Jain, Jayanshu, Frees, Melanie, Yasin, Hesham, Bonner, Jaime, Freesmeier, Michele, Garje, Rohan, Venur, Vyshak Alva, Milhem, Mohammed, Zakharia, Yousef

Volltext

Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study von Sun, Di, Hadjiiski, Lubomir, Alva, Ajjai, Zakharia, Yousef, Joshi, Monika, Chan, Heang-Ping, Garje, Rohan, Pomerantz, Lauren, Elhag, Dean, Cohan, Richard H, Caoili, Elaine M, Kerr, Wesley T, Cha, Kenny H, Kirova-Nedyalkova, Galina, Davenport, Matthew S, Shankar, Prasad R, Francis, Isaac R, Shampain, Kimberly, Meyer, Nathaniel, Barkmeier, Daniel, Woolen, Sean, Palmbos, Phillip L, Weizer, Alon Z, Samala, Ravi K, Zhou, Chuan, Matuszak, Martha

Volltext

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible von Frydenlund, Noah, Zakharia, Yousef, Garje, Rohan, Dahmoush, Laila, O’Donnell, Michael A.

Volltext

Comprehensive review of chromophobe renal cell carcinoma von Garje, Rohan, Elhag, Dean, Yasin, Hesham A, Acharya, Luna, Vaena, Daniel, Dahmoush, Laila

Volltext

Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation von Garje, Rohan, Rumble, R. Bryan, Parikh, Rahul A.

Volltext

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer von Garje, Rohan, An, Josiah, Obeidat, Mohammad, Kumar, Kranthi, Yasin, Hesham A., Zakharia, Yousef

Volltext

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer von Sartor, Oliver, de Bono, Johann, Chi, Kim N, Fizazi, Karim, Herrmann, Ken, Rahbar, Kambiz, Tagawa, Scott T, Nordquist, Luke T, Vaishampayan, Nitin, El-Haddad, Ghassan, Park, Chandler H, Beer, Tomasz M, Armour, Alison, Pérez-Contreras, Wendy J, DeSilvio, Michelle, Kpamegan, Euloge, Gericke, Germo, Messmann, Richard A, Morris, Michael J, Krause, Bernd J

Volltext